2021: Year of the Cold Chain
With COVID-19 vaccine production complete and distributors urgently looking for ways to transport it safely, all eyes are on the effectiveness of the cold chain. Early vaccine candidates require ultra-low temperatures, as much as -70 degrees Celsius©, or -94 degrees Fahrenheit. This is influenced by a lack of data storage specifications and shelf life for these new types of Messenger RNA (mRNA) vaccines. The containers to store and transport them are not widely available and not required for common vaccines. Constant temperature control is needed E2E from the manufacturing site to the inoculation sites.